Use of proteomic patterns in plasma as a novel screening tool in pre eclampsia

This pilot study aimed to use Ciphergen ProteinChip® technology to determine differences in protein profiles in plasma, taken at 26 weeks, from women at risk of developing pre-eclampsia. Five proteins were found to be significantly up-regulated in samples from women who subsequently developed pre-eclampsia compared with women who remained normotensive.